Navigation Links
Aquavit Pharmaceuticals and U-Bio Med Enter Exclusive Worldwide License Agreement for Microneedle Technology (AQT-001)
Date:7/18/2013

NEW YORK, July 18, 2013 /PRNewswire/ -- Aquavit Pharmaceuticals, Inc. announces it has signed a definitive licensing agreement with U-Bio Med Inc., a medical technology device company in South Korea, for the worldwide commercialization of the company's microneedle device technology. 

The definitive agreement, signed on July 14, 2013, provides Aquavit Pharmaceuticals a perpetual exclusive right to license, sub-license, improve and/or commercialize the patented microneedle technology and all of its derivatives.  The companies have not disclosed the deal amount.

"Dr. Eum is an exceptional scientist. The technology will accelerate our consorted development towards disruptive innovation in drug delivery," said Sobin Chang, Aquavit's Chief Executive Officer.

Aquavit will own all intellectual property pertaining to further development of Aquavit's pipeline products.  The company has begun the registration process with the FDA and CE for specialized use.

"In addition to the patented delivery mechanism of the needles, we are using pure gold to ensure quality and safety," said Dr. Nyun-Sik Eum, CEO of U-Bio Med.

AQT-001 has been FDA registered and will be commercially available in US and globally shortly.  The technology will address the unmet needs of the 11 billion dollar medical aesthetics market and the 30 billion dollar vitamin and mineral market.

"It is an innovative delivery system for botulinum toxins and dermal fillers.  I use it with Botox, hyaluronic acid-based fillers and vitamin combinations," said Dr. David Shafer, Chief Medical Technology Officer.

About U-Bio Med Inc.

U-Bio Med (Ubiquitous Bio Medical Equipment) is a Korean company that specializes in the development and manufacturing of precise test equipment, bio-sensor based optical systems and practical medical devices.  

About Aquavit Pharmaceuticals, Inc.

Aquavit Pharmaceuticals is a multi-specialty healthcare company focused on discovering, developing and commercializing innovative pharmaceuticals, medical device, and health technologies. For more information, visit www.aquavitpharma.com or contact Anne Hargreaves at 212-210-9272.


'/>"/>
SOURCE Aquavit Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Aquavit and Green Cross Sign Strategic Collaboration MOU on IBX-001 Product Development and Commercialization in Asia
2. Aquavit Pharmaceuticals forms Alliance Partnership with Accelrys
3. Aquavit Pharmaceuticals Inc. Appoints David Shafer, MD., FACS., New Chief Medical Technology Officer
4. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
5. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
6. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
7. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
8. Icahn Issues Statement Regarding Amylin Pharmaceuticals
9. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
10. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
11. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2017)... -- Bayer has awarded grants totaling more than $2 million to ... Bayer Hemophilia Awards Program (BHAP). Four U.S. clinicians and researchers ... and Uniformed Services University of the Health Sciences in ... were announced last night during a reception at the International ... Berlin, Germany . ...
(Date:7/11/2017)...  Sysmex America, Inc., a leading provider of ... well as middleware information systems technology, today announced ... assurance easier and more risk free than manual ... the innovation that it delivers to the laboratory. ... processes to a new level with automated, continuous ...
(Date:7/11/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ( ... development of oral drug delivery systems, announced today that ... to schedule an End-of-Phase II meeting with Oramed for ... insulin capsule ORMD-0801 in the treatment of type 2 ... endpoints by indicating a statistically significant lowering of glucose ...
Breaking Medicine Technology:
(Date:7/20/2017)... ... 2017 , ... Girl Up Campaign Director, Melissa Kilby, released ... support of providing girls access to education in refugee settings. In May, Congressman Steve ... Access to Education in Vulnerable Settings Act.” Yesterday, companion legislation was introduced in ...
(Date:7/20/2017)... , ... July 20, 2017 , ... ... products that further expand its existing adherence automation lines. The ATP® Mini and ... the advanced technology of TCG’s standard products, but at a size and price ...
(Date:7/20/2017)... ... 20, 2017 , ... With nearly half of all Americans ... company VisitorsCoverage Inc. has launched TMQuotes, a new cloud-based solution platform which gives ... under their own brand. The online marketplace bridges the technological gap in the ...
(Date:7/20/2017)... Henderson, Tennessee (PRWEB) , ... July 19, 2017 ... ... successful second year with a larger audience and increased funds raised to support ... two evening performances of “Disney Aladdin Kids” in Freed-Hardeman University’s Loyd Auditorium. ...
(Date:7/20/2017)... ... July 19, 2017 , ... Med Tech Solutions (MTS), a ... Health IT business unit of Constellation Inc., a move that will help the company ... operations in St. Louis, the acquisition is expected to help MTS expand ...
Breaking Medicine News(10 mins):